2017/2018 Medicare Part D Plan Comparison:  Compare annual changes for all Medicare Part D plans or Medicare Advantage in your state. Medicaid Transformation Find your Plan (3) That payments must not be made to individuals and entities included on the preclusion list, defined in § 422.2 of this chapter. Plans and Services Search our site or contact us. By Mail Already a Member? BlueCross BlueShield of South Carolina is an independent licensee of the Blue Cross and Blue Shield Association. Have/offered job-based insurance 11. Preclusion List—Part C/Medicare Advantage Cost Plan and PACE Provisions * * * * * The requirement for a minimum number of cases is needed to address statistical concerns with precision and small numbers. If a contract meets only one of the conditions, the contract would not be subject to reductions for IRE data completeness issues. 2018 ENROLLMENT AREA Medicare Allows More Benefits for Chronically Ill, Aiming to Improve Care for Millions In April 2010, we clarified our authority to deny contract qualification applications from organizations that have failed to comply with the requirements of a Medicare Advantage or Part D plan sponsor contract they currently hold, even if the submitted application otherwise demonstrates that the organization meets the relevant program requirements. As part of that rulemaking, we established, at § 422.502(b)(1) and § 423.503(b)(1), that we would review an applicant's prior contract performance for the 14-month period preceding the application submission deadline (see 75 FR 19684 through 19686). We conduct that review in accordance with a methodology we publish each year [58] and use to score each applicant's performance by assigning weights based on the severity of its non-compliance in several Start Printed Page 56441performance categories. Under the annual contract qualification application submission and review process we conduct, organizations must submit their application by a date, usually in mid-February, announced by us. We now propose to reduce the past performance review period from 14 months to 12 months. If you have a Health Savings Account (HSA) or health insurance based on current employment, you may want to ask your personnel office or insurance company how signing up for Medicare will affect you. We solicit comment on our proposal to add non-substantive updates to measures and using the updated measure (replacing the legacy measure) to calculate Star Ratings. In particular, we are interested in stakeholders' views whether only non-substantive updates that have been adopted by a measure steward after a consensus-based or notice and comment process should be added to the Star Ratings under this proposed authority. Further, we solicit comment on whether there are other examples or situations involving non-substantive updates that should be explicitly addressed in the regulation text or if our proposal is sufficiently extensive. Lost your password? (1) The calculated error rate is 20 percent or more. 2018 Guide to Retirement Planning • Did not enroll in a Medicare prescription drug plan when first eligible for Medicare; or Julie's Story § 423.120 To see the networks for the ACO options, go to Medica ACO Plan. Prescription drug list Iodine Deficiency Linked to Lower Odds of Pregnancy Certain Medicare beneficiaries Enrollees would have a free choice of medical providers, which would include any provider that participates in the current Medicare program. Copayments would be lower for patients who choose centers of excellence that deliver high-quality care, as determined by such measures as the rate of hospital readmissions. Your information contains error(s): 172 UPDATE 4-U.S. judge bars Kentucky from requiring Medicaid recipients to work Medicare Select Including survey measures of physicians' experiences. (Currently, we measure beneficiaries' experiences with their health and drug plans through the CAHPS survey.) Physicians also interact with health and drug plans on a daily basis on behalf of their patients. We are considering developing a survey tool for collecting standardized information on physicians' experiences with health and drug plans and their services, and we would welcome comments.Start Printed Page 56378

Call 612-324-8001

The Centers for Medicare and Medicaid Services, which administers programs under the Affordable Care Act, said the action affects $10.4 billion in risk adjustment payments. For Metallic Plan Members: Start Printed Page 56400 Read more Benefits Exchange Health care reform in the United States (iv) Case Management/Clinical Contact/Prescriber Verification (§ 423.153(f)(2)) Breast Cancer 15.3 Non-governmental links This proposed regulatory provision would implement statutory provisions of the Comprehensive Addiction and Recovery Act of 2016 (CARA), enacted into law on July 22, 2016, which amended the Social Security Act and includes new authority for Medicare Part D drug management programs, effective on or after January 1, 2019. Through this provision, CMS proposes a framework under which Part D plan sponsors may establish a drug management program for beneficiaries at risk for prescription drug abuse or misuse, or “at-risk beneficiaries.” CMS proposes that, under such programs, sponsors may limit at-risk beneficiaries' access to coverage of controlled substances that CMS determines are “frequently abused drugs” to a selected prescriber(s) and/or network pharmacy(ies). CMS also proposes to limit the use of the special enrollment period (SEP) for dually- or other low income subsidy (LIS)-eligible beneficiaries who are identified as at-risk or potentially at-risk for prescription drug abuse under such a drug management program. Finally, this provision proposes to codify the current Part D Opioid Drug Utilization Review (DUR) Policy and Overutilization Monitoring System (OMS) by integrating this current policy with our proposals for implementing the drug management program provisions. The current policy involves Part D prescription drug benefit plans engaging in case management with prescribers when an enrollee is found to be taking a very high dose of opioids and obtaining them from multiple prescribers and multiple pharmacies who may not know about each other. Through the adoption of this policy, from 2011 through 2016, there was a 61 percent decrease (over 17,800 beneficiaries) in the number of Part D beneficiaries identified as potential very high risk opioid overutilizers.[1] Thus, this proposal expands upon an existing, innovative, successful approach to reduce opioid overutilization in the Part D program by improving quality of care through coordination while maintaining access to necessary pain medications. e. Approval of Tiering Exception Requests (N) The reduction is identified by the highest threshold that a contract's lower bound exceeds. Medicare Part D Plans Qualifying Life Events This is your place Position Designation Tool Activities that improve health care quality. (1) Medicare Plan Finder Performance icons. Icons are displayed on Medicare Plan Finder to note performance as provided in this paragraph (h): § 422.2272 Alternative Quality Contract Over time new measures will be added and measures will be removed from the Star Ratings program to meet our policy goals. As new measures are added, our general guidelines for deciding whether to propose new measures through future rulemaking will use the following criteria: CMS proposes here to amend § 422.100(f)(6) to clarify that it may use Medicare FFS data to establish appropriate cost sharing limits. In addition, CMS intends to use MA utilization encounter data to inform patient utilization scenarios used to help identify MA plan cost sharing standards and thresholds that are not discriminatory; we solicit comment on whether to codify that use of MA encounter data for this purpose in § 422.100(f)(6). This proposal is not related to a statutory change. EXPLORE PLANS child pages Accordingly, we propose § 423.153(f)(9) to read: Beneficiary preferences. Except as described in paragraph (f)(10) of this section, if a beneficiary submits preferences for prescribers or pharmacies or both from which the beneficiary prefers to obtain frequently abused drugs, the sponsor must do the following—(i) Review such preferences and (ii) If the beneficiary is—(A) Enrolled in a stand-alone prescription drug benefit plan and specifies a prescriber(s) or network pharmacy(ies) or both, select or change the selection of prescriber(s) or network pharmacy(ies) or both for the beneficiary based on beneficiary's preference(s) or (B) Enrolled in a Medicare Advantage prescription drug benefit plan and specifies a network prescriber(s) or network pharmacy(ies) or both, select or change the selection of prescriber(s) or pharmacy(ies) or both for the beneficiary based on the beneficiary's preference(s). If the beneficiary submits preferences for a non-network pharmacy(ies), or in the case of a Medicare Advantage prescription drug benefit plan a non-network prescriber(s), or both, the sponsor does not have to select or change the selection for the beneficiary to a non-network pharmacy or prescriber except if necessary to provide reasonable access. Gym Discounts c. Treatment of Accreditation and Other Similar Any Willing Pharmacy Requirements in Standard Terms and Conditions Getting Started with IBD 13. Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2018; Amendments to Special Enrollment Periods and the Consumer Operated and Oriented Plan Program; Department of Health and Human Services; Dec. 22, 2016. © 2018 Commonwealth of Massachusetts. Additional Benefits with Your Medical Plan Generally, no. It’s against the law for someone who knows you have Medicare to sell you a Marketplace plan. Recent changes ‌$ We are proposing in §§ 422.166(e) and 423.186(e) to continue the current weighting of measures in the Part C and D Star Ratings program by assigning the highest weight (5) to improvement measures, followed by outcome and intermediate outcome measures (weight of 3), then by patient experience/complaints and access measures (weight of 1.5), and finally process measures (weight of 1). We are considering increasing the weight of the patient experience/complaints and access measures and are interested in stakeholder feedback on this potential change in order to reflect better the importance of these issues in plan performance. If we were to increase the weight, we are considering increasing it from a weight of 1.0 to between 1.5 and 3 similar to outcome measures. This increased weight would reflect CMS' commitment to serve Medicare beneficiaries by putting the patients first, including their assessments of the care received by plans. We solicit comment on this point, particularly the potential change in the weight of the patient experience/complaints and access measures. Health Insurance Plans with Independence Blue Cross Slider Menu The plan change must occur within 60 days of the qualifying life event. Drug Category or Class: We are considering requiring that the manufacturer rebate amount applied to the point-of-sale price for a covered drug be based on the plan's average rebate amount calculated for the rebated drugs in the same category or class. We are considering requiring sponsors to determine the average rebate amount at the therapeutic category or class level, rather than a drug-specific rebate amount, in order to maintain the confidentiality of any manufacturer-sponsor/PBM pricing relationship with respect to an individual drug. Given that rebate rates are typically negotiated at the individual drug level, we believe that the drug category/class-average approach we are considering would help maintain fair competition among drug manufacturers, as well as Part D sponsors, by preventing competitors from reverse engineering the particulars of any proprietary pricing arrangement. This approach would also increase price transparency over the status quo, especially at the drug category or class level, and improve market competition and efficiency under Part D as a result. In addition to feedback on this general approach and our rationale for it, we are seeking comment, in particular, on the drug classification system that Part D sponsors should be required to use to calculate their drug category/class-level average rebate amounts and why that system would be most appropriate for use in such a point-of-sale rebate policy. We also are seeking comment on the effect of calculating average rebates at the drug category/class level on competition and, in turn, on the total rebate dollars received. Section 1860D-4(g)(2) of the Act specifies that a beneficiary enrolled in a Part D plan offering prescription drug benefits for Part D drugs through the use of a tiered formulary may request an exception to the plan sponsor's tiered cost-sharing structure. The statute requires such plan sponsors to have a process in place for making determinations on such requests, consistent with guidelines established by the Secretary. At the start of the Part D program, we finalized regulations at § 423.578(a) that require plan sponsors to establish and maintain reasonable and complete exceptions procedures. These procedures permit enrollees, under certain circumstances, to obtain a drug in a higher cost-sharing tier at the more favorable cost-sharing applicable to alternative drugs on a lower cost-sharing tier of the plan sponsor's formulary. Such an exception is granted when the plan sponsor determines that the non-preferred drug is medically necessary based on the prescriber's supporting statement. The tiering exceptions regulations establish the general scope of issues that must be addressed under the plan sponsor's tiering exceptions process. Our goal with the exceptions rules codified in the Part D final rule (70 FR 4352) was to allow plan sponsors sufficient flexibility in benefit design to obtain pricing discounts necessary to offer optimal value to beneficiaries, while ensuring that beneficiaries with a medical need for a non-preferred drug are afforded the type of drug access and favorable cost-sharing called for under the law. RSS Also, if you are leaving employer coverage in the middle of your Medicare Initial Enrollment Period, then your IEP trumps any other election period. We’ve seen this a number of times where people assume their Medicare coverage will start immediately after the group coverage ends. Make the most of your Humana plan Who do I contact for extra help? I have employer coverage, current page Read the stories of other people enrolling in Medicare to learn what they’re focused on, what they want most out of Medicare and what choices they’ll be making. Annual Election My Kind of Blue Get the most out of your plan. Register for a MyHumana account today. Loading your Profile... 6.138% 6.134% loan - 10 years $50,000 To lower both the level and growth of health care costs, provider payment rates under Medicare Extra would reference current Medicare rates. Currently, Medicaid rates are lower than Medicare rates, and both are significantly lower than commercial insurance rates.25 Medicare Extra rates would be lower than current commercial rates in noncompetitive areas where hospitals reap windfalls, but higher than current Medicaid and Medicare rates. INSURANCE BASICS Employer Plans a. By revising the definition of “Affected enrollee”; Healthy Lifestyles, Wellness and Prevention 500 http error (ii) A contract is assigned 2 stars if it does not meet the 1 star criteria and meets at least one of the following criteria: The Medicare Rights Center raises concerns about enhanced benefits that are not available to everyone. Finance Leaders: Learn which policy areas you should watch in 2018 Dun & Bradstreet See 2018 plan Petrofund Meetings & Minutes myBlueWellness Medicare and Rural Health (Rural Health Information Hub) COBA Trading Partners Yes. You can delay Part B enrollment if you’re getting health coverage through the SHOP Marketplace based on your or your spouse’s job. (C)(1) Its average CAHPS measure score is at or above the 60th percentile and lower than the 80th percentile; No links available CMA Health Policy Consultants Cost Saving Tips (2) The authorized individual must thoroughly describe how the entity and MA plan meet, or will meet, all the requirements described in this part, including providing documentation that payment for health care services or items is not being and will not be made to individuals and entities included on the preclusion list, defined in § 422.2. 2018 Clean Energy Community Award Winners w. Technical Changes Excelsior on Facebook Excelsior on Twitter Excelsior on LinkedIn The actuarial value of the typical large employer preferred provider organization (PPO) is 85 percent and the actuarial value of the FEHBP Standard Option is 80 percent (Table B2). See Frank McArdle and others, “How Does the Benefit Value of Medicare Compare to the Benefit Value of Typical Large Employer Plans? A 2012 Update” (Menlo Park, CA: Kaiser Family Foundation, 2012), available at https://kaiserfamilyfoundation.files.wordpress.com/2013/01/7768-02.pdf; Large employers contribute an average of 81 percent of the premium for single coverage and 72 percent of the premium for family coverage (Figure 6.24). Premium contributions for part-time employees would be in proportion to hours worked per week divided by 40 hours. See Kaiser Family Foundation, “2017 Employer Health Benefits Survey” (2017), available at https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/. ↩ (iii) Patient experience and complaint measures receive a weight of 1.5. Original Medicare: Jump up ^ Judy Feder, Lisa Clemans-Cope, Teresa Coughlin, John Holahan, Timothy Waidmann, "Refocusing Responsibility For Dual Eligibles: Why Medicare Should Take The Lead." Robert Wood Johnson Foundation, October 2011. http://www.rwjf.org/files/research/72868qs68dualeligiblesfull20110930.pdf Plan: UMP Consumer-Directed Health Plan (UMP CDHP) HEALTHY NY You will pay late penalties amounting to an extra 10 percent for each full 12-month period that had elapsed between the end of your IEP and the GEP in which you finally signed up — minus any time in which you had insurance from active employment (your own or your spouse's). Part B penalties must be paid for as long as you remain in Medicare. If you get penalties for late Part A sign-up (which is possible only if you have to pay premiums for Part A), you'll pay them for twice the number of years that you'd delayed enrollment. (2) Beneficiary preference; We note that under our current policy, plan sponsors send only one notice to the beneficiary if they intend to implement a beneficiary-specific POS opioid claim edit, which generally provides the beneficiary with a 30-day advance written notice and opportunity to provide additional information, as well as to request a coverage determination if the beneficiary disagrees with the edit. If our proposal is finalized, the implementation of a beneficiary-specific POS claim edit or a limitation on the at-risk beneficiary's coverage for frequently abused drugs to a selected pharmacy(ies) or prescriber(s) would be an at-risk determination (a type of initial determination that would confer appeal rights). Also, the sponsor would generally be required to send two notices—the first signaling the sponsor's intent to implement a POS claim edit or limitation (both referred to generally as a “limitation”), and the second upon implementation of such limitation. Under our proposal, the requirement to send two notices would not apply in certain cases involving at-risk beneficiaries who are identified as such and provided a second notice by their immediately prior plan's drug management program. Call 612-324-8001 Cigna | Beaver Bay Minnesota MN 55601 Lake Call 612-324-8001 Cigna | Brimson Minnesota MN 55602 St. Louis Call 612-324-8001 Cigna | Finland Minnesota MN 55603 Lake
Legal | Sitemap